Cirrhosis-related hyponatremia and the role of tolvaptan

被引：9
作者：
Iwasa, Motoh [1 ]
Ishihara, Tomoaki [2 ]
Hasegawa, Hiroshi [1 ]
Takei, Yoshiyuki [1 ]
机构：
[1] Mie Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Tsu, Mie 514, Japan
[2] Yokkaichi Digest Dis Ctr, Dept Gastroenterol & Hepatol, Yokaichi, Japan
来源：
HEPATOLOGY RESEARCH | 2015年 / 45卷 / 10期
关键词：
ASCITES;
D O I：
10.1111/hepr.12471
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E163 / E165
页数：3
相关论文
共 9 条
  • [1] Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis
    Ahluwalia, Vishwadeep
    Heuman, Douglas M.
    Feldman, George
    Wade, James B.
    Thacker, Leroy R.
    Gavis, Edith
    Gilles, HoChong
    Unser, Ariel
    White, Melanie B.
    Bajaj, Jasmohan S.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 (01) : 75 - 82
  • [2] Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis
    Cardenas, Andres
    Gines, Pere
    Marotta, Paul
    Czerwiec, Frank
    Oyuang, John
    Guevara, Monica
    Afdhal, Nezam H.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 (03) : 571 - 578
  • [3] Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia
    Dahl, E.
    Gluud, L. L.
    Kimer, N.
    Krag, A.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (07) : 619 - 626
  • [4] Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death
    Heuman, DM
    Abou-assi, SG
    Habib, A
    Williams, LM
    Stravitz, RT
    Sanyal, AJ
    Fisher, RA
    Mihas, AA
    [J]. HEPATOLOGY, 2004, 40 (04) : 802 - 810
  • [5] Urine Sodium Excretion After Tolvaptan Administration Is Dependent Upon Baseline Serum Sodium Levels A Possible Explanation for the Improvement of Hyponatremia With Scarce Chance of Hypernatremia by a Vasopressin Receptor Antagonist
    Imamura, Teruhiko
    Kinugawa, Koichiro
    Minatsuki, Shun
    Muraoka, Hironori
    Kato, Naoko
    Inaba, Toshiro
    Maki, Hisataka
    Hatano, Masaru
    Yao, Atsushi
    Komuro, Issei
    [J]. INTERNATIONAL HEART JOURNAL, 2014, 55 (02) : 131 - 137
  • [6] Patients with hyponatremic cirrhosis have low-grade cerebral edema and poor quality-of-life
    Iwasa, Motoh
    Sugimoto, Ryosuke
    Takei, Yoshiyuki
    [J]. ANNALS OF HEPATOLOGY, 2014, 13 (03) : 407 - 408
  • [7] Tolvaptan for improvement of hepatic edema: A phase 3, multicenter, randomized, double-blind, placebo-controlled trial
    Sakaida, Isao
    Kawazoe, Seiji
    Kajimura, Kozo
    Saito, Takafumi
    Okuse, Chiaki
    Takaguchi, Koichi
    Okada, Mitsuru
    Okita, Kiwamu
    [J]. HEPATOLOGY RESEARCH, 2014, 44 (01) : 73 - 82
  • [8] Serum sodium concentration is associated with increased risk of mortality in patients with compensated liver cirrhosis
    Umemura, Takeji
    Shibata, Soichiro
    Sekiguchi, Tomohiro
    Kitabatake, Hiroyuki
    Nozawa, Yuichi
    Okuhara, Sadahisa
    Kimura, Takefumi
    Morita, Susumu
    Komatsu, Michiharu
    Matsumoto, Akihiro
    Tanaka, Eiji
    [J]. HEPATOLOGY RESEARCH, 2015, 45 (07) : 739 - 744
  • [9] Short-term effects of low-dose tolvaptan on hemodynamic parameters in patients with chronic heart failure
    Watanabe, Kiyotaka
    Dohi, Kaoru
    Sugimoto, Tadafumi
    Yamada, Tomomi
    Sato, Yuichi
    Ichikawa, Kazuhide
    Sugiura, Emiyo
    Kumagai, Naoto
    Nakamori, Shiro
    Nakajima, Hiroshi
    Hoshino, Kozo
    Machida, Hirofumi
    Okamoto, Shinya
    Onishi, Katsuya
    Nakamura, Mashio
    Nobori, Tsutomu
    Ito, Masaaki
    [J]. JOURNAL OF CARDIOLOGY, 2012, 60 (5-6) : 462 - 469
1